Neuropharmacology of depression in aging and age-related diseases.
about
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.Aging of the hypothalamic-pituitary-adrenal axis in nonhuman primates with depression-like and aggressive behavior.Noradrenaline and Parkinson's disease.The interesting interplay between interneurons and adult hippocampal neurogenesis.Reconsidering Animal Models of Major Depressive Disorder in the Elderly.The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice.Psychometric properties of the Persian version of Social Adaptation Self-evaluation Scale in community-dwelling older adults.Improving effect of chronic resveratrol treatment on central monoamine synthesis and cognition in aged rats.Depression-like behavior is dependent on age in male SAMP8 mice.Ingestion of theanine, an amino acid in tea, suppresses psychosocial stress in mice.Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Dopamine-Related Genotypes and Physical Activity Change During an Intervention: The Lifestyle Interventions and Independence for Elders Study.Investigation of Behavioral Dysfunctions Induced by Monoamine Depletions in a Mouse Model of Parkinson's DiseaseGenetic Risk for Psychiatric Disorders and Telomere Length
P2860
Q33751924-59482CAC-D076-4A13-828A-D22978AAA8DCQ34395267-5AA47026-9F43-4D47-B52C-12E2FD2B49F6Q34424926-46A7046E-3F53-4AE2-A4DC-61BDC24D52FCQ35013240-9E37CE32-887A-49C5-803C-0CF47384A054Q37131406-CD975875-246D-4210-B7C2-CEDB0EB76603Q37156767-F18D76E8-1AAB-4C50-B0BA-20A264A70600Q37295518-DA9B1CE8-ACE9-4B53-A917-0E3D33F158DCQ37732380-966AC364-F350-4B9C-B6EA-469910888622Q39822759-ACBE0919-5597-42C0-8290-E5987A04C0D5Q43645029-41E31342-1FE0-44F0-A6DA-788FBCED9973Q43772318-B65D5D88-F72B-44B2-A6BE-753B6172F98CQ46622861-3CC5090D-1D4E-4CAB-BFA9-4AEAEC0282E7Q47137783-538A03F7-3ACA-4E73-9557-30F4F03A8BF6Q52594721-43370971-D1CD-438F-B03D-4E90458987BEQ58795485-44DBF68C-D6FF-4EA4-8998-FAFADBA9115AQ59128040-8979FAA5-B235-4EE1-B58A-474A614F0183
P2860
Neuropharmacology of depression in aging and age-related diseases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neuropharmacology of depression in aging and age-related diseases.
@ast
Neuropharmacology of depression in aging and age-related diseases.
@en
Neuropharmacology of depression in aging and age-related diseases.
@nl
type
label
Neuropharmacology of depression in aging and age-related diseases.
@ast
Neuropharmacology of depression in aging and age-related diseases.
@en
Neuropharmacology of depression in aging and age-related diseases.
@nl
prefLabel
Neuropharmacology of depression in aging and age-related diseases.
@ast
Neuropharmacology of depression in aging and age-related diseases.
@en
Neuropharmacology of depression in aging and age-related diseases.
@nl
P2093
P1476
Neuropharmacology of depression in aging and age-related diseases.
@en
P2093
Giovambattista De Sarro
Pasquale De Fazio
Pietro Gareri
P304
P356
10.1016/S0047-6374(01)00370-0
P577
2002-02-01T00:00:00Z